MedDataX Logo

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

NCT00171106 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-11-18

No results posted yet for this study

Summary

This study will test the effects of valsartan versus placebo on exercise tolerance in patients with symptoms of heart failure

Conditions

  • Diastolic Dysfunction, Symptomatic Heart Failure

Interventions

DRUG

valsartan

Sponsors & Collaborators

  • Novartis

    lead INDUSTRY

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2007-08-31
Completion
2008-02-29

Countries

  • Germany
  • Switzerland

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00171106 on ClinicalTrials.gov